117 related articles for article (PubMed ID: 4040419)
1. Uterine papillary serous carcinoma. Complete response to combination chemotherapy.
Fitzgerald D; Rosenthal S
Cancer; 1985 Sep; 56(5):1023-4. PubMed ID: 4040419
[TBL] [Abstract][Full Text] [Related]
2. Uterine papillary serous carcinoma with high levels of serum carcinoembryonic antigen. Response to combination chemotherapy.
Fukuma K; Miyamura S; Thoya T; Tanaka N; Fujisaki S; Okamura H; Maeyama M
Cancer; 1987 Feb; 59(3):403-5. PubMed ID: 2431759
[TBL] [Abstract][Full Text] [Related]
3. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
Turbow MM; Ballon SC; Sikic BI; Koretz MM
Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
[TBL] [Abstract][Full Text] [Related]
5. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Price FV; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1993 Dec; 51(3):383-9. PubMed ID: 8112650
[TBL] [Abstract][Full Text] [Related]
6. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Chambers JT; Chambers SK; Kohorn EI; Carcangiu ML; Schwartz PE
Gynecol Oncol; 1996 Mar; 60(3):438-42. PubMed ID: 8774654
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic approach to uterine papillary serous carcinoma.
Hamaguchi K; Komai K; Sakihama H; Okura N; Nagasue N; Nishida T; Yakushiji M
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):367-72. PubMed ID: 2129190
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
10. The importance of chemotherapy and radiation in uterine papillary serous carcinoma.
Viswanathan AN; Macklin EA; Berkowitz R; Matulonis U
Gynecol Oncol; 2011 Dec; 123(3):542-7. PubMed ID: 21963091
[TBL] [Abstract][Full Text] [Related]
11. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
Levin L; Hryniuk W
Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
[TBL] [Abstract][Full Text] [Related]
12. Complete response to docetaxel and carboplatin combination chemotherapy for a stage IV uterine papillary serous carcinoma: a case report.
Kashima K; Aoki Y; Yahata T; Tanaka K
Int J Gynecol Cancer; 2005; 15(6):1199-202. PubMed ID: 16343213
[TBL] [Abstract][Full Text] [Related]
13. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma.
Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914
[TBL] [Abstract][Full Text] [Related]
16. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
Deppe G; Lin Liu T
Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
Piver MS; Fanning J; Baker TR
Am J Clin Oncol; 1991 Jun; 14(3):200-2. PubMed ID: 2031506
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy and endocrine therapy of endometrial carcinoma].
Kanuma T; Matsuzawa M
Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
